Michael J. Fox Foundation for Parkinson's Research logo
Program

Parkinson's Disease Proteoforms Program

Offers Parkinson's Disease Proteoforms Program, supporting proteoform biomarker research to improve Parkinson's disease understanding and diagnostics.

The Parkinson's Disease Proteoforms Program sits under the Michael J. Fox Foundation for Parkinson's Research and funds high-resolution proteoform datasets from Parkinson's brain tissue and matched biofluids. The work is organized around two tracks, Global Proteoform Profiling and Tau Proteoform Characterization. Awards are up to $1 million for as long as 24 months. The program is open globally, applicants may submit to both tracks with separate applications, and MJFF provides samples from Banner Sun Health Research Institute. The current cycle closes with full proposals due July 21, 2026, and the award announcement is planned for the week of November 2, 2026. This route suits teams that can deliver well-annotated proteoform data and share it under MJFF's open-science rules. Discovery-only approaches, method development, and preclinical or in vitro models are outside scope. The page also gives no extra PI or organization restrictions, which keeps the route broadly open. Teams that already have proteomics depth and a clear analysis plan are the best match.

BiotechMedtechNeurotech

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Last verified: 29 May 2026Source: www.michaeljfox.org